Volume 14 Supplement 1

IPF in 2011 - Key updates on guidelines and therapeutics


Edited by Ulrich Costabel

This supplement originates from presentations given at the symposium AIR: Advancing IPF Research. Working together to translate IPF research into practice held in Berlin in November 2011. The publication was supported by IntraMed Communications with funding from InterMune, AG. The content was proposed by IntraMed Communications and developed with the journal. All articles in the supplement have undergone the journal's standard peer review process.

AIR: Advancing IPF Research. Working together to translate IPF research into practice.

Berlin, Germany

4-5 November 2011

  1. Research

    Highlights of HRCT imaging in IPF

    High-resolution computed tomography (HRCT) imaging has a central role in the diagnosis of interstitial lung diseases, particularly in the evaluation of patients with suspected idiopathic pulmonary fibrosis (IP...

    N Sverzellati

    Respiratory Research 2013 14(Suppl 1):S3

    Published on: 16 April 2013

  2. Research

    Recommendations on treatment for IPF

    Patient management in Idiopathic Pulmonary Fibrosis (IPF) is largely based on societal guidelines and recommendations. A recent update by the American Thoracic Society (ATS), European Respiratory Society (ERS)...

    Jürgen Behr and Luca Richeldi

    Respiratory Research 2013 14(Suppl 1):S6

    Published on: 16 April 2013

  3. Research

    Where do we stand with IPF treatment?

    Despite receiving ‘weak no’ recommendations in the updated guidelines on treating patients with Idiopathic Pulmonary Fibrosis (IPF), two key treatment options are pirfenidone and N-acetylcysteine (NAC), and bo...

    C Albera, C Ferrero, E Rindone, S Zanotto and E Rizza

    Respiratory Research 2013 14(Suppl 1):S7

    Published on: 16 April 2013